Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ABBOTT LABORATORIES

(ABT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Abbott Laboratories : Gets FDA Clearance for Portico with FlexNav Transcatheter Aortic Valve Replacement

09/20/2021 | 11:00am EDT


© MT Newswires 2021
All news about ABBOTT LABORATORIES
10/21GLOBAL MARKETS LIVE : Tesla, Unilever, Paypal, Elliott, Novartis...
10/21ABBOTT LABORATORIES : UBS Adjusts Price Target on Abbott Laboratories to $138 From $131, M..
MT
10/21ABBOTT LABORATORIES : JPMorgan Adjusts Price Target for Abbott Laboratories to $140 From $..
MT
10/21ABBOTT LABORATORIES : Morgan Stanley Adjusts Abbott Laboratories' Price Target to $146 fro..
MT
10/21ABBOTT LABORATORIES : SVB Leerink Adjusts Abbott Laboratories' Price Target to $140 from $..
MT
10/21ABBOTT LABORATORIES : Raymond James Adjusts Price Target on Abbott Laboratories to $134 fr..
MT
10/21ABBOTT LABORATORIES : Reports third-quarter 2021 results, achieves strong double-digit ear..
AQ
10/20Dow Jones Industrial Average : Strong earnings reports lift Wall Street
RE
10/20Brinker, Baker Hughes fall; Anthem, Abbott Laboratories rise
AQ
10/20Health Care Stocks Rally for Second Consecutive Day
MT
More news
Analyst Recommendations on ABBOTT LABORATORIES
More recommendations
Financials (USD)
Sales 2021 41 861 M - -
Net income 2021 6 575 M - -
Net Debt 2021 8 432 M - -
P/E ratio 2021 34,3x
Yield 2021 1,34%
Capitalization 225 B 225 B -
EV / Sales 2021 5,57x
EV / Sales 2022 5,73x
Nbr of Employees 109 000
Free-Float 88,8%
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 25
Last Close Price 126,72 $
Average target price 135,61 $
Spread / Average Target 7,02%
EPS Revisions
Managers and Directors
Robert B. Ford President, CEO, Chief Operating Officer & Director
Robert Emmett Funck Chief Financial Officer & Executive VP-Finance
Miles D. White Executive Chairman
Sabina Ewing Chief Investment Officer, VP-Business & Technology
Roxanne Schuh Austin Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ABBOTT LABORATORIES15.74%224 651
MEDTRONIC PLC3.85%163 718
BECTON, DICKINSON AND COMPANY-1.50%70 784
HOYA CORPORATION21.65%55 133
DEXCOM, INC.53.24%54 963
SARTORIUS STEDIM BIOTECH64.49%51 865